CDIO vs CGEM

Cardio Diagnostics Holdings Inc vs Cullinan Therapeutics, Inc. — Valuation Comparison 2026

CDIO

Biotechnology
Cardio Diagnostics Holdings Inc
Quality
4.3
out of 10
Value Trap
30
LOW
Price
$1.80
Last close
Models
9/13
Active
VS

CGEM

Biotechnology
Cullinan Therapeutics, Inc.
Quality
4.4
out of 10
Value Trap
24
SAFE
Price
$15.36
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CDIO Fair ValueCDIO Upside CGEM Fair ValueCGEM Upside
Bayesian DCF Intrinsic $1.37 -23.8% $4.78 -68.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.17 -88.6% $1.71 -88.9%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CDIO vs CGEM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CDIO vs CGEM — Which Stock Is More Undervalued?

CGEM scores higher with a 4.4/10 quality rating vs CDIO's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cardio Diagnostics Holdings Inc (CDIO) and Cullinan Therapeutics, Inc. (CGEM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CDIO currently trades at $1.80 with a QOC of 4.3/10, while CGEM trades at $15.36 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).